Cite
HARVARD Citation
Hauschild, A. et al. (2020). Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials. European journal of cancer. pp. 114-120. [Online].